R Chávez Domínguez, JA Ramírez Hernández, JM Casanova Garcés

Language: Spanish
References: 17
Page: 105-114
PDF size: 89.25 Kb.

ABSTRACT

Coronary heart disease is dominant among heart diseases in the population, a problem to control. Heart diseases have been first place in the general mortality for the last 20 years. The trend show an annual increase without control. Atherosclerosis is responsible for at least for one fourth of all deaths in the country. The combined data of mortality and morbidity, from hospital discharges or the whole country, disclose that one out of three die of acute myocardial infarction (AMI). While only 8% of all deaths registered were admitted to a hospital. Most, 92% were never admitted to any hospital for some reason. The estimated annual incidence of AMI cases is 140,000, on the basis of 3 cases surviving for each case death, accounted by the Death Certification System, which rounds 35,000. Standardized mortality rates of AMI in Mexico are greater than in USA o Canada creating a more concerned worry. The most probable explanation to that situation is lack of preventive care, which should also include the acute care and before reaching the hospital facilities. Running the same chances are hypertension crisis and strokes and diabetic complications. The appropriate care for critical situations might reduce significantly the cardiovascular mortality in the country, in a short and middle term. Prevention is not only for chronic conditions but for acute and critical situations. The programs of preventive care should also include cultural promotion and community awareness. The timely care is life and myocardium saving. The reinforcement of prior to hospital care reduces the delay for AMI adequate intervention. These activities agree quite well with the ongoing programs of CPR, organizing the surviving chain and the training programs for paramedical emergency technicians.

REFERENCES

1. Sackett DL, Straus ES, Richardson WS, Rosenberg W, Haynes RB: Evidence. Bases Medicine. 2nd Ed. Toronto Churchill Livingston, 2000.

2. Chávez DR: Mortalidad de las enfermedades cardiovasculares en México. Artículo Especial. Arch Inst Cardiol Méx 1979; 49: 303-323.

3. González MJ, Del Bosque S, Del Bosque MT: Manos a la Salud. Mercadotecnia, Comunicación y Publicidad: Herramientas para la Promoción de la Salud. Centro Interamericano de Estudios de Seguridad Social y Organización Panamericana de la Salud, 1997

4. Gordon T, Kannel WB: The prospective study of cardiovascular diseases. En: Stewart G. Trends in Epidemiology Chapter 6. Springfield Illinois USA, Ed. Charles C Thomas Publ. American Lecture Series, 1972 p.189-211.

5. Puska P, Tuomilehto J, Nissinen A, Vartiainen E: The North Karelia Project. 20 Year Results and Experiences. National Public Health Institute (KTL), Finland 1995.

6. Una Conferencia Internacional Sobre Promoción de la Salud. Carta de Ottawa Para la Promoción de la Salud Organización Mundial de la Salud, Salud y Bienestar Social Canadá, Asociación Canadiense de Salud Pública. Ottawa (Ontario) Canadá 17-21 de Noviembre 1986

7. Chavez DR: Issues and challenges for CVD prevention in Ibero-America: The challenge of human resource development. Can J Cardiol 1993: 9; Suppl D may: 195D-196D.

8. Chavez DR: Aterosclerosis. Vínculo de altruismo. En las enfermedades crónico degenerativas. Rev Vinculación. Subsecretaría de Educación SEP: ANUIES; GIRSA, SA 1999; 14: 15-19.

9. Dirección General de Estadística e Informática. Estadísticas Vitales, Daños a la Salud y Mortalidad. México, Secretaría de Salud; 2002.

10. Curtin LR. Klein RJ: Direct Standardization (Age-Adjusted Death Rates) Statistical Notes NCHS 1995; 6: 1-10.

11. Global Cardiovascular Infobase. Map and Webpage. http://cvdinfobase.ic.gc.ca/. Creado, 2002, Abr. 24, 11:42:38.

12. Braunwald E, Cannon C, McCabe CH: Use of composite endpointsin thrombolysis trials of acute myocardial infaction. Am J Cardiol 1993,72: 3G-132G.

13. Velásquez MO: Nuevos horizontes para el desarrollo de la prevención y control de las enfermedades cardiovasculares. Puntos de vista de las instituciones públicas. En Chávez DR. Coordinador de Declaración Ajusco 2000 Por la Salud del Corazón. Publicación de la Sociedad Mexicana de Cardiología. México, Cortesía Pfizer SA de CV; 2001

14. Velásquez MO, Rosas PM, Lara EA, Pastelin HG, Attie F, Tapia CR: Hipertensión arterial en México: Resultados de la Encuesta Nacional de Salud (ENSA) 2000. Arch Cardiol Mex 2002; 72: 71-84

15. Newman MM, Christenson J: Challenging Sudden Death. A Community Guide to Help Save Lives. Catalyst Research & Communications, Inc. Carmel, Indiana 1998.

16. Jerjes-Sanchez C: Trombolisis farmacológica en el Infarto Agudo del Miocardio: Lecciones Aprendidas Después del ISIS-2 y del GUSTO-1 En Jerjes-Sanchez C Aspectos Selectos en Urgencias Cardiovasculares. 1997 Bristol-Myers Squibb de México S de RL de CV.

17. Chávez DR: (Ed Coord) Declaración Ajusco 2000 Por la Salud del Corazón. Publicación de la Sociedad Mexicana de Cardiología. México, Cortesía Pfizer SA de CV; 2001.